Avesta76
1 known investors
Find your way into Avesta76
Avesta Bio is a biotech company developing cancer therapeutics by targeting oxidative stress and its role in disease, based on the approach of identifying what is common across cancer cells rather than what differs. Its research points to methods of killing many cancer cell types without harming normal cells, with potential applications to other metabolic diseases.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSEEDNov 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Avesta76 do?
- Avesta Bio is a biotech company developing cancer therapeutics by targeting oxidative stress and its role in disease, based on the approach of identifying what is common across cancer cells rather than what differs. Its research points to methods of killing many cancer cell types without harming normal cells, with potential applications to other metabolic diseases.
- Who are Avesta76's investors?
- Avesta76's investors include Cancer Fund.